ARNIs improve the survival rate of heart failure patients by inhibition of neprilysin which leads to an increase in ANP (atrial natriuretic peptide) and BNP (brain natriuretic peptide) levels, which in turn has beneficial effects on preload, inflammation, and fibrosis [13,14]. Here, NPPB is linked to heart failure.